Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ariad Pharmaceuticals, Inc.    ARIA

Delayed Quote. Delayed  - 04/29 09:59:59 pm
7.18 USD   +0.14%
04/28 ARIAD PHARMACEU : Specific NSCLC Patients Show Improvement in Clinic..
04/26 ARIAD PHARMACEU : to Webcast Conference Call on First Quarter 2016 F..
04/19 ARIAD PHARMACEU : Announces Results of Preclinical Studies on AP3278..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/25/2016 04/26/2016 04/27/2016 04/28/2016 04/29/2016 Date
7.36(c) 7.25(c) 7.22(c) 7.17(c) 7.18(c) Last
2 165 529 2 396 973 2 307 971 2 365 401 2 611 245 Volume
0.00% -1.49% -0.41% -0.69% +0.14% Change
More quotes
Financials ($)
Sales 2016 212 M
EBIT 2016 -161 M
Net income 2016 -166 M
Debt 2016 58,9 M
Yield 2016 -
Sales 2017 269 M
EBIT 2017 -131 M
Net income 2017 -128 M
Debt 2017 142 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales 2016 6,71x
EV / Sales 2017 5,59x
Capitalization 1 364 M
More Financials
Company
ARIAD Pharmaceuticals, Inc. operates as an oncology company which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer.Its products include Iclusig and Caregivers.The company was founded by Harvey J. Berger in April 1991 and is... 
More about the company
Surperformance© ratings of Ariad Pharmaceuticals, Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ARIAD PHARMACEUTICALS, INC
04/29 MEDTRONIC : Best Regions for Genetics Research
04/28 ARIAD PHARMACEUTICALS : Presents Updated Phase 1/2 Clinical Data on Brigatinib i..
04/28 ARIAD PHARMACEUTICALS : Announces Results of Preclinical Studies on AP32788 at t..
04/28 ARIAD PHARMACEUTICALS : Specific NSCLC Patients Show Improvement in Clinical Tri..
04/26 ARIAD PHARMACEUTICALS : to Webcast Conference Call on First Quarter 2016 Financi..
04/25 ARIAD PHARMACEUTICALS INC : Other Events (form 8-K)
04/21 ARIAD PHARMACEUTICALS : Announces Initiation of Randomized, First-Line Phase 3 T..
04/19 ARIAD PHARMACEUTICALS : Announces Results of Preclinical Studies on AP32788 at t..
More news
Sector news : Bio Therapeutic Drugs
04/29 SANOFI : offers to buy Medivation for $9.3bn
04/29 SANOFI : France's Sanofi makes $9.3 billion bid for US cancer drug giant
04/29DJSanofi Seeks Talks With Medivation Over $9.3 Billion Offer -- 2nd Update
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
04/25 Two execs bid adieu at ARIAD Pharma
04/15 Phase 1/2 trial of ARIAD Pharma's brigatinib shows 100% one-year survival rat..
04/15 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
04/11 ARIAD Pharma kicks off late-stage study of brigatinib in lung cancer
03/18 Transgenomic debuts new lung cancer biomarker test


Comments 
Advertisement
Chart ARIAD PHARMACEUTICALS, INC
Duration : Period :
Ariad Pharmaceuticals, Inc Technical Analysis Chart | ARIA | US04033A1007 | 4-Traders
Full-screen chart
Technical analysis trends ARIAD PHARMACEUTI...
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions